Mettler Toledo vs Teradyne
Mettler Toledo makes precision instruments and laboratory balances for pharmaceutical, chemical, and food quality control applications where accuracy is non-negotiable, while Teradyne builds automated test equipment for semiconductors and electronics manufacturing where speed and precision drive yield improvements. Both sell high-precision capital equipment into technically demanding markets with long customer relationships and strong aftermarket service revenue. The Mettler Toledo vs Teradyne comparison examines how lab instrument stability compares to semiconductor test equipment's cyclicality and which business model sustains richer margins through the full industrial cycle.
Mettler Toledo makes precision instruments and laboratory balances for pharmaceutical, chemical, and food quality control applications where accuracy is non-negotiable, while Teradyne builds automated...
Why It's Moving
Analysts See +15% Upside for MTD in 2026 Amid Bullish Earnings Outlook
- Analysts project median price targets implying 14-17% gains, backed by 'Moderate Buy' consensus from 7 Buy and 7 Hold ratings.
- Upcoming Q1 earnings expected to deliver EPS of $46.51, up sharply from last year's $42.73, highlighting operational strength.
- MTD shares have risen 30.6% over the past year, outpacing healthcare peers and underscoring resilience in a competitive market.
TER Stock Warning: Why Analysts See -33% Downside Risk
- Stock dropped 1.29% to $90.15 on July 25, 2025, after falling 8.59% from a pivot top on July 10, signaling ongoing weakness until a new bottom forms.
- Short- and long-term moving averages both issue sell signals, with resistance looming at $92.82 and $90.39, curbing any near-term rebound hopes.
- MACD shows a sell signal over three months, amplifying negative momentum in a volatile market averaging 2.90% daily swings last week.
Analysts See +15% Upside for MTD in 2026 Amid Bullish Earnings Outlook
- Analysts project median price targets implying 14-17% gains, backed by 'Moderate Buy' consensus from 7 Buy and 7 Hold ratings.
- Upcoming Q1 earnings expected to deliver EPS of $46.51, up sharply from last year's $42.73, highlighting operational strength.
- MTD shares have risen 30.6% over the past year, outpacing healthcare peers and underscoring resilience in a competitive market.
TER Stock Warning: Why Analysts See -33% Downside Risk
- Stock dropped 1.29% to $90.15 on July 25, 2025, after falling 8.59% from a pivot top on July 10, signaling ongoing weakness until a new bottom forms.
- Short- and long-term moving averages both issue sell signals, with resistance looming at $92.82 and $90.39, curbing any near-term rebound hopes.
- MACD shows a sell signal over three months, amplifying negative momentum in a volatile market averaging 2.90% daily swings last week.
Investment Analysis
Pros
- Mettler-Toledo has a dominant competitive position in precision instruments for laboratories and industry, with strong brand recognition among global customers.
- The company recently delivered both earnings and revenue above consensus estimates in Q3 2025, suggesting robust demand and operational execution.
- Mettler-Toledo consistently generates high returns on invested capital and maintains efficient operations, requiring minimal reinvestment for sustained cash flow.
Considerations
- Revenue growth has been sluggish over the past two years, with organic sales barely growing, indicating plateauing core business momentum.
- Analysts expect only modest sales growth in the near term, with forecasts below sector averages despite recent quarterly outperformance.
- The stock trades at a premium valuation relative to peers and its historical average, increasing sensitivity to earnings disappointments or sector rotation.
Teradyne
TER
Pros
- Teradyne benefits from strong exposure to semiconductor test equipment, a critical and growing segment amid ongoing global chip demand and innovation cycles.
- The company’s share price has significantly appreciated over the past year, reflecting investor optimism about its market position and growth prospects.
- Teradyne’s balance sheet remains solid, with no major liquidity concerns and capacity to invest in next-generation test technologies.
Considerations
- Teradyne’s valuation multiples are elevated, with a price-to-earnings ratio far above the market average, implying high expectations for future performance.
- The stock exhibits heightened volatility, with a wide 52-week trading range, reflecting sensitivity to semiconductor industry cycles and macroeconomic swings.
- Dividend yield remains minimal, offering little income appeal compared to other industrial or technology peers with more established shareholder return policies.
Mettler Toledo (MTD) Next Earnings Date
Mettler-Toledo International (MTD) is scheduled to release its Q1 2026 earnings after market close on Thursday, May 7, 2026, with a conference call the following morning at 8:30 a.m. Eastern Time. This follows their most recent Q4 2025 report on February 5, 2026. Investors should monitor for the official release confirming these details.
Teradyne (TER) Next Earnings Date
Teradyne (TER) is scheduled to release its Q1 2026 earnings results after market close on Tuesday, April 28, 2026, with a conference call to follow on Wednesday, April 29 at 8:30 AM ET. Analysts are expecting earnings per share of $2.08 and revenue of approximately $1.1872 billion for the quarter. This earnings release will provide investors with the company's latest financial performance and forward guidance.
Mettler Toledo (MTD) Next Earnings Date
Mettler-Toledo International (MTD) is scheduled to release its Q1 2026 earnings after market close on Thursday, May 7, 2026, with a conference call the following morning at 8:30 a.m. Eastern Time. This follows their most recent Q4 2025 report on February 5, 2026. Investors should monitor for the official release confirming these details.
Teradyne (TER) Next Earnings Date
Teradyne (TER) is scheduled to release its Q1 2026 earnings results after market close on Tuesday, April 28, 2026, with a conference call to follow on Wednesday, April 29 at 8:30 AM ET. Analysts are expecting earnings per share of $2.08 and revenue of approximately $1.1872 billion for the quarter. This earnings release will provide investors with the company's latest financial performance and forward guidance.
Buy MTD or TER in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
